Animal & Veterinary
-
FDA Veterinarian Newsletter 2002 - Volume XVII, No VI
-
Table of Contents
DR. VAUGHN SELECTED AS ONADE DIRECTOR [ARCHIVED]CVM JOINS PEW INITIATIVE FOR PUBLIC MEETING ON CLONING [ARCHIVED]
by Jon F. ScheidVETERINARIANS MAY NOT PRESCRIBE THALIDOMIDE [ARCHIVED]REMINDER - EXTRA-LABEL USE OF FLUOROQUINOLONES PROHIBITED [ARCHIVED]FDA LEVERAGING INITIATIVE IN LINE WITH PRESIDENT'S MANAGEMENT AGENDA: PART II - LEVERAGING ACTIVITIES IN CVM [ARCHIVED]
by David Batson, Ph.D. and Melissa StarinskyCVM ATTENDS WORLD DAIRY EXPO AND AVMA CONVENTION [ARCHIVED]DEVELOPMENT OF A STANDARDIZATION SUSCEPTIBILITY TESTING METHOD FOR CAMPYLOBACTER [ARCHIVED]
by P. F. McDermott, Ph.D., S. M. Bodeis and R. D. Walker, D.V.M.REGULATORY ACTIVITIES - November/December 2002 [ARCHIVED]
by Karen A. KandraINTERNATIONAL ACTIVITIES - VICH 2 [ARCHIVED]U.K. SCIENTIST VISITS OR [ARCHIVED]CVM STUDENT INTERN SUMMER PROGRAM [ARCHIVED]CVM COMINGS AND GOINGS - November/December 2002 [ARCHIVED]UPDATED INFORMATION ON RUMINANT FEED REGULATIONS [ARCHIVED]ANIMAL FEED USE OF MATERIAL FROM CERTAIN FREE RANGE DEER AND ELK [ARCHIVED]DRAFT GUIDANCE ON ADMINISTRATIVE NADA PROCESS AVAILABLE FOR COMMENT [ARCHIVED]SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS - November/December 2002 [ARCHIVED]
-
-
-







